Batten Disease Market Manufacturing Development & Analysis by
Region to 2017
“Batten disease, a rare genetic disorder, belongs to a group of progressive
degenerative neurometabolic disorders known as the neuronal ceroid
lipofuscinoses. Symptoms of Batten disease usually become apparent
between five and 15 years of age.”
Batten Disease, a rare genetic disorder, belongs to a group of progressive degenerative neurometabolic
disorders known as the neuronal ceroid lipofuscinoses. Symptoms of Batten disease usually become apparent
between five and 15 years of age. Symptoms include vision loss, lack of muscle coordination, mental
retardation or decreasing mental function, emotional disturbances, seizures, muscle spasms, deterioration of
muscle tone and movement problems.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Batten Disease Pipeline Review, H2 2017, provides
comprehensive information on the therapeutics under development for Batten Disease (Central Nervous
System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and press releases.
Browse Detail Report With TOC @
https://www.hexareports.com/report/batten-disease-pipeline-review-h2-2017
Follow Us: